Skin tolerability and efficacy of combination therapy with hydrogen peroxide stabilized cream and adapalene gel in comparison with benzoyl peroxide cream and adapalene gel in common acne. A randomized, investigator-masked, controlled trial
- PMID: 15327558
- DOI: 10.1111/j.1365-2133.2004.06067.x
Skin tolerability and efficacy of combination therapy with hydrogen peroxide stabilized cream and adapalene gel in comparison with benzoyl peroxide cream and adapalene gel in common acne. A randomized, investigator-masked, controlled trial
Abstract
Background: Combination therapy with antiseptics such as benzoyl peroxide (BP) and topical retinoids is widely used as first-line treatment for acne vulgaris (AV). However, these combinations could have a suboptimal skin tolerability. Recently, a new formulation of hydrogen peroxide (HP) 1% in stabilized cream (Crystacide; Mipharm, Milan, Italy) became available. A previous clinical study has shown that HP cream monotherapy presents a better skin tolerability in comparison with BP in patients with mild AV.
Objectives: To evaluate the tolerability and the efficacy of combination therapy with HP cream and adapalene 0.1% gel in comparison with the combination of BP 4% cream and adapalene 0.1% gel in the treatment of mild to moderate AV.
Methods: In a randomized, investigator-blinded trial, 52 patients (mean +/- SD age 25 +/- 6 years; 19 men and 33 women) with AV were randomly assigned to HP cream and adapalene gel (group HP + A) or to BP cream and adapalene gel (group BP + A), for eight consecutive weeks. Efficacy was assessed by total (TL), inflammatory (IL) and noninflammatory (NL) lesion counts performed at baseline and weeks 4 and 8. Tolerability was assessed by evaluating skin erythema, burning and dryness at weeks 4 and 8.
Results: All patients completed the study. At baseline, the mean +/- SD numbers of TL, IL and NL were 44 +/- 9, 25 +/- 7 and 19 +/- 6 in group HP + A and 40 +/- 9, 21 +/- 7 and 19 +/- 9 in group BP + A, respectively. At the end of the treatment period, TL, IL and NL were reduced by 93%, 92% and 95%, respectively, in group HP + A and by 88%, 86% and 90%, respectively, in group BP + A. A significantly (P = 0.0025) greater reduction in NL was observed in group HP + A in comparison with group BP + A. Tolerability was significantly better in group HP + A in comparison with group BP + A (P = 0.02). Skin dryness and burning sensation were more frequent in group BP + A.
Conclusions: The combination of adapalene and HP cream is an effective topical treatment regimen in mild to moderate AV. This combination has shown a better tolerability profile in comparison with the combination of BP and adapalene.
Similar articles
-
Adapalene 0.1%/benzoyl peroxide 2.5% gel: a review of its use in the treatment of acne vulgaris in patients aged ≥ 12 years.Am J Clin Dermatol. 2011 Dec 1;12(6):407-20. doi: 10.2165/11208170-000000000-00000. Am J Clin Dermatol. 2011. PMID: 21967116 Review.
-
Adapalene-benzoyl peroxide, a unique fixed-dose combination topical gel for the treatment of acne vulgaris: a transatlantic, randomized, double-blind, controlled study in 1670 patients.Br J Dermatol. 2009 Nov;161(5):1180-9. doi: 10.1111/j.1365-2133.2009.09209.x. Epub 2009 May 21. Br J Dermatol. 2009. PMID: 19466959 Clinical Trial.
-
A North American study of adapalene-benzoyl peroxide combination gel in the treatment of acne.Cutis. 2009 Aug;84(2):110-6. Cutis. 2009. PMID: 19746769 Clinical Trial.
-
The tolerability profile of clindamycin 1%/benzoyl peroxide 5% gel vs. adapalene 0.1%/benzoyl peroxide 2.5% gel for facial acne: results of a randomized, single-blind, split-face study.J Cosmet Dermatol. 2012 Dec;11(4):251-60. doi: 10.1111/jocd.12013. J Cosmet Dermatol. 2012. PMID: 23174047 Clinical Trial.
-
Adapalene 0.1% and benzoyl peroxide 2.5%: a novel combination for treatment of acne vulgaris.Skin Therapy Lett. 2009 Jul-Aug;14(6):4-5. Skin Therapy Lett. 2009. PMID: 19609474 Review.
Cited by
-
Topical benzoyl peroxide for acne.Cochrane Database Syst Rev. 2020 Mar 16;3(3):CD011154. doi: 10.1002/14651858.CD011154.pub2. Cochrane Database Syst Rev. 2020. PMID: 32175593 Free PMC article.
-
Performance and Safety of the Medical Device Ialuxid Gel in the Treatment of Mild-Moderate Acne Vulgaris: An Open-Label, Noncomparative Multicentre Interventional Clinical Trial.J Cosmet Dermatol. 2025 Mar;24(3):e70084. doi: 10.1111/jocd.70084. J Cosmet Dermatol. 2025. PMID: 40029154 Free PMC article. Clinical Trial.
-
Development of Ratiometric Fluorescence Sensors Based on CdSe/ZnS Quantum Dots for the Detection of Hydrogen Peroxide.Sensors (Basel). 2019 Nov 15;19(22):4977. doi: 10.3390/s19224977. Sensors (Basel). 2019. PMID: 31731661 Free PMC article.
-
Results of a Multicenter, Randomized, Controlled Trial of a Hydrogen Peroxide-based Kit versus a Benzoyl Peroxide-based Kit in Mild-to-moderate Acne.J Clin Aesthet Dermatol. 2016 Oct;9(10):50-54. Epub 2016 Oct 1. J Clin Aesthet Dermatol. 2016. PMID: 27847549 Free PMC article.
-
Hydrogen Peroxide: A Potential Wound Therapeutic Target?Med Princ Pract. 2017;26(4):301-308. doi: 10.1159/000475501. Epub 2017 Apr 5. Med Princ Pract. 2017. PMID: 28384636 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous